AusBiotech’s Post

The medtech world is at a crossroads of regulatory evolution. How do we adapt and thrive amidst these global shifts? #AusMedtech2024 hosted in Adelaide on 22-23 May, offers a keynote not to be missed.   Gain vital insights as the Therapeutic Goods Administration (TGA) charts the course through a time of transformative change in medical device regulation. This session is pivotal for anyone in the #medtech field looking to understand:   🔹 The TGA's current strategies for regulating new technologies. 🔹 The TGA's support mechanisms for industry adaptation. 🔹 The impact of regulatory changes on Australian healthcare.   Join chair, Karen Parr, Director of Policy & Communications at AusBiotech, and the esteemed Professor Tony Lawler, the new head of the TGA, as they shed light on the future direction.   Secure your place now while early-bird tickets are still available! Your ticket to #AMT24 not only opens the door to this session but also to a realm of opportunities to connect with medtech industry leaders and innovators.   #AMT24 #medtech #SA

  • text

To view or add a comment, sign in

Explore topics